Among patients with moderate to severe atopic dermatitis, APG777 produced significant reductions in disease severity at 16 ...

EVO301, a long-acting, injectable interleukin-18 binding protein, rapidly improved moderate to severe atopic dermatitis in ...

Daily application of roflumilast cream for 52 weeks improves the signs and symptoms of AD in patients with various comorbid atopic conditions.

The phase 2b REZOLVE-AD trial enrolled 393 adults with moderate-to-severe atopic dermatitis across approximately 110 global ...

For people living with atopic dermatitis, the real test of any new therapy is not what it can do in a few months, but whether it can keep angry, inflamed skin quiet over the long haul. Nektar ...

EBGLYSS™ (EHB-glihs) is an injectable medicine used to treat adults and children 12 years of age and older who weigh at least 88 pounds (40 kg) with moderate-to-severe eczema (atopic dermatitis) that ...

A topic dermatitis is a chronic condition that tends to rear its itchy head during certain periods before subsiding — for months, possibly, or even years. It particularly affects the insides of the ...

* DUPIXENT ® is the only biologic medicine approved by Health Canada to treat moderate-to-severe atopic dermatitis. * Public reimbursement under the Ontario Exceptional Access Program and the New ...

How do dermatologists diagnose atopic dermatitis? To diagnose atopic dermatitis, also called eczema, a board-certified dermatologist carefully examines your (or your child's) skin and asks questions. ...

If your current eczema routine only offers temporary relief, it may be time for a change. Learn how to address underlying inflammation and find a treatment that fits your busy lifestyle.

Many people use atopic dermatitis and eczema interchangeably, but they are two different conditions. Eczema is a general term for skin inflammation. Atopic dermatitis is the most common type of eczema ...